Effects of White Wine vs. Tea Intake During and an Alcoholic Digestive Following a High Fat, High Calorie Cheese Fondue Meal on Gastric Emptying and Abdominal Symptoms in Healthy Volunteers

Overview

Tradition holds that the intake of different drinks with a meal has an important influence on the digestion of food and postprandial symptoms such as fullness, bloating and satiety; however this assumption have never been subjected to controlled study A classic example is the Swiss cheese fondue. The intake of white wine, tea and cherry schnapps (Kirsch) are often attributed either positive or negative effects on the gastrointestinal tract. In this study the effect of white wine vs. tea intake during and an alcoholic digestive following a high fat, high calorie Swiss fondue meal on gastric emptying and visceral perception will be investigated using a randomized, controlled study design. The fondue will be labeled with non-radioactive 13C octanoate for assessment of gastric emptying by breath-test.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2009

Interventions

  • Dietary Supplement: Ingestion of white wine vs. tea during and an alco
    • 4 x 50ml glasses of white wine (12% alcohol) or tea will be taken according to a randomization scheme After the meal 1 x 20ml of Kirsch (40% alcohol) or tea will be taken

Clinical Trial Outcome Measures

Primary Measures

  • Effect of white wine vs. tea on gastric emptying
    • Time Frame: 4 hours

Participating in This Clinical Trial

Inclusion Criteria

• able to communicate well with the investigators and provide written consent • Body Mass Index: 19-30 kg/m2 Exclusion criteria:

• physical co-morbidity requiring active treatment

  • psychiatric (DSM IV) disorders limiting the ability to comply with study – use of medications influencing upper GI motility – evidence of current drug or alcohol abuse – history of gastrointestinal disease or surgery except appendicectomy or hernia repair

Gender Eligibility: All

Minimum Age: 19 Years

Maximum Age: 60 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Zurich
  • Collaborator
    • COOP
  • Provider of Information About this Clinical Study
    • Dr. Mark Fox, University of Zurich
  • Overall Official(s)
    • 01 Studienregister MasterAdmins, Study Director, UniversitaetsSpital Zuerich

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.